The 2025 YouGov survey data from more than 31,000 US adults show significant support for recreational cannabis legalization, medical use, and federal reclassification.
|Articles|March 29, 2023
Oregon Issues First Psilocybin License to Portland Business
Author(s)Erin McEvoy
Oregon Psilocybin Services (OPS) issued first psilocybin manufacturer license since accepting applications earlier this year.
Advertisement
On March 22, 2023, Oregon Health Authority (OHA) announced the granting of the first psilocybin license to a woman-owned business–Satori Farms PDX LLC (1). In 2020, Oregon legalized psilocybin for therapeutic purposes and created the nation’s first regulatory framework for psilocybin services (2). The newly created Oregon Psilocybin Services (OPS) began accepting license applications in January and expects to issue more licenses to laboratories, service centers, and facilitators in the coming months (1).
“We congratulate Tori Armbrust of Satori Farms PDX LLC for being issued the first psilocybin license in Oregon’s history and for representing women leading the way for the emerging psilocybin ecosystem,” said OPS Section Manager Angie Allbee in the OHA announcement (1). “We are committed to fostering an inclusive partnership with our regulated community to ensure safe, effective and equitable psilocybin services throughout the state.”
Information for finding licensed psilocybin service centers and facilitators can be found on the OPS Licensee Directory website.
Earlier this month the first students graduated from training programs to become certified psilocybin therapy facilitators (3).
For an in-depth look at the regulations surrounding Oregon’s legalized psilocybin industry, check out this Cannabis Science and Technology blog entry from Kim Stuck, CEO and founder of Allay Consulting:
References
Advertisement
Related to this article
Curaleaf is opening a new cannabis dispensary called Curaleaf Millcreek in Erie, Pennsylvania.
Learn how third-party audits enhance compliance in the cannabis industry, ensuring readiness for evolving regulations and fostering consumer trust.
Let’s take a look at the 2025 cannabis coverage on medical cannabis research and medicine to catch up on industry trends and innovations.
Let’s take a look at the 2025 cannabis coverage on cannabis research to catch up on industry trends and innovations.
A lack of standards for cannabis vape devices puts consumers at risk, but several organizations are committed to the research, collaboration, and solutions needed to promote safety and quality in the industry.
Cannabis genetics fundamentally dictate the plant's potential for chemical signatures, including cannabinoid and terpene profiles, and physical traits, such as yield. Cultivators use selective techniques, such as "stacking," to enhance specific compounds. Ultimately, successful cultivation involves balancing superior genetics with environmental "levers" to optimize gene expression and create targeted strains.
It’s that time of year again—the Cannabis Science and Technology (CST) top 10 articles from the previous year. CST published a wide variety of content throughout 2025. Here is just a small snippet of some of the top articles that our readers enjoyed. See if any of your favorites made the list!
Advertisement
Advertisement